Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1160789-91-2 | MDL No. : | MFCD22571291 |
Formula : | C7H4BrFN2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RPCKLZZTGOIHCJ-UHFFFAOYSA-N |
M.W : | 247.09 | Pubchem ID : | 59603094 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 51.68 |
TPSA : | 67.15 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.81 cm/s |
Log Po/w (iLOGP) : | 1.96 |
Log Po/w (XLOGP3) : | 2.82 |
Log Po/w (WLOGP) : | 3.21 |
Log Po/w (MLOGP) : | 2.44 |
Log Po/w (SILICOS-IT) : | 3.5 |
Consensus Log Po/w : | 2.79 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.7 |
Solubility : | 0.0489 mg/ml ; 0.000198 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.89 |
Solubility : | 0.032 mg/ml ; 0.00013 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.75 |
Solubility : | 0.0441 mg/ml ; 0.000179 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With sodium hydride In 1-methyl-pyrrolidin-2-one at 130℃; for 2 h; | To a solution of (5-Bromo-2,4-difluoro-phenyl)-thiourea (0.75 g, 2.80 mmol) in NMP (5.0 mL) was added NaH (0.17 g, 4.21 mmol, 60percent dispersion in oil) portion wise. The reaction mixture was then heated at 13O0C for 2 h. The reaction mixture was then poured onto crushed ice and extracted with EtOAc (3 x 50 mL). The combined organics was evaporated to get the crude residue that was purified over silica gel (100-200 M, 12percent EtOAc-Hexane) to obtain the desired compound (0.36 g, 52percent). 1H- NMR (400 MHz, DMSO-d6): δ 7.57 (d, J= 6.40 Hz, 1 H), 7.66 (br s, 2H) and 7.79 (d, 8.80 Hz, 1 H). |
52% | With sodium hydride In 1-methyl-pyrrolidin-2-one; mineral oil at 130℃; for 2 h; | To a solution of ii (0.75 g, 2.80 mmol) in NMP (5.0 mL) was added NaH (0.17 g, 4.21 mmol, 60percent dispersion in oil) portion wise. The mixture was heated at 130° C. for 2 h. and then poured onto crushed ice and extracted with EtOAc (3*50 mL). The combined organics were evaporated. Purification by chromatography on silica eluting with 12percent EtOAc-Hexane gave iii (0.36 g, 52percent). 1H-NMR (400 MHz, DMSO-d6): δ 7.57 (d, J=6.40 Hz, 1H), 7.66 (br s, 2H) and 7.79 (d, 8.80 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | Stage #1: at 10 - 100℃; Stage #2: With ammonia In water |
1 -(3-Bromo-4-fluorophenyi)thiourea (3.77g, 15.1 mmo.) was solved in acetic acid (156 mL) and cooled to I CCC. Bromine (3.63 g, 22.7 mmol) in acetic acid (69 mL) was added and after 15 minutes the mixture was heated to 100°C for 2 hours. A solution of sodium bisulphite was added and the mixture was heated shortly to 100 under vigorous stirring while the mixture lost its bromine colour. The mixture was concentrated under reduced pressure, the residue suspended in aqueous ammonia and the alkaline mixture was extracted multiple times with dichioromethane. The organic extracts were concentrated and solved in methanol (40 mL). Water (60 mL) was added and the forming precipitate collected by filtration. The precipitate was purified by chromatography on silica gel (ethyl acetate in hexane 12 to 50percent) to give 0.90 g (23percent) of 5-bromo-6-fluoro-1,3-benzothiazol-2-amine: H NMR (300 MHz, DMSO-cfe) δ = 7.57 (d, 1 H), 7.67 (s, 2H), 7.78 (d, 1 H) ppm. |
[ 20358-06-9 ]
4-Fluorobenzo[d]thiazol-2-amine
Similarity: 0.79
[ 78364-55-3 ]
6-Fluoro-2-hydrazinylbenzo[d]thiazole
Similarity: 0.79
[ 348-40-3 ]
6-Fluorobenzo[d]thiazol-2-amine
Similarity: 0.74
[ 788124-34-5 ]
5,7-Difluorobenzo[d]thiazol-2-amine
Similarity: 0.72
[ 103873-80-9 ]
5-Bromo-4-methylbenzo[d]thiazol-2-amine
Similarity: 0.80
[ 1216671-97-4 ]
2-Amino-5-bromobenzo[d]thiazole 3-oxide
Similarity: 0.75
[ 75104-92-6 ]
6-Bromo-N-methylbenzo[d]thiazol-2-amine
Similarity: 0.73
[ 103873-80-9 ]
5-Bromo-4-methylbenzo[d]thiazol-2-amine
Similarity: 0.80
[ 20358-06-9 ]
4-Fluorobenzo[d]thiazol-2-amine
Similarity: 0.79
[ 78364-55-3 ]
6-Fluoro-2-hydrazinylbenzo[d]thiazole
Similarity: 0.79
[ 1216671-97-4 ]
2-Amino-5-bromobenzo[d]thiazole 3-oxide
Similarity: 0.75